Skip to main content

Can Chloroquine and Hydroxychloroquine Treat COVID-19?

Coronavirus COVID-19 Treatment with Chloroquine and Hydroxychloroquine

Since the anti-malarial drugs chloroquine and hydroxychloroquine entered the big stage of "new coronary pneumonia, old medicine and new use", the storm has been constant.
Sweden, France and many other countries discontinued (hydroxy) chloroquine treatment of COVID-19 patients. 

Former FDA leader condemned EUA of anti-malarial drugs

The former leader of the FDA condemned the emergency use authorization (EUA) of anti-malarial drugs, which he believes undermines the scientific authority of the FDA. 

The official website of the US Centers for Disease Control and Prevention (CDC) has published a medication guide titled "Clinicians' Information on Treatment Options for Patients with New Coronary Pneumonia". 
This includes the key doses of the drugs chloroquine and hydroxychloroquine for COVID-19 Information. But this remains published 3 days only.
CDC deleted this guide from the official website. 

And Rick Bright, director of the US Agency for Advanced Research and Development in Biomedicine (BARDA), was forced to leave because he resisted funding for the promotion of unproven anti-malarial drugs for COVID-19.

In terms of clinical research, earlier this month, researchers in Brazil stopped some studies of hydroxychloroquine because some patients experienced heart rhythm problems after undergoing tests with two higher doses of drugs. 

Conducted by the US Veterans Health Administration Medical Center After the study, it was found that the experimental group of "receiving hydroxychloroquine treatment" new coronary pneumonia "has a higher mortality rate"!
The researchers also tested the effect of combining with azithromycin. 
The result is that whether it is combined with azithromycin or not, will not reduce the risk of using a ventilator.

Recently, chloroquine and hydroxychloroquine have recurred

According to an internal e-mail published by the American magazine Vanity Fair, the Trump administration pressured federal government health officials to provide the public with the malaria drug chloroquine for COVID treatment without medical supervision -19. 

This strategy also caused panic and opposition from scientists and doctors of some federal health agencies, who expressed their refusal to suspend drug regulation.

This Friday, the FDA released a new drug safety report. 
This report is a drug safety bulletin on known side effects of hydroxychloroquine and chloroquine, including serious and potentially life-threatening heart rhythm problems. 

This is the first time the FDA has issued relevant content for the treatment of COVID-19 patients with hydroxychloroquine and chloroquine since the emergency authorization of hydroxychloroquine and chloroquine.

FDA's adverse event reporting system

According to the FDA, according to the case report in the database of the FDA's adverse event reporting system, it is known that COVID-19 patients have serious heart rhythm problems when receiving drugs or similar compounds chloroquine (usually combined with the antibiotic azithromycin).

The drugs used to treat arthritis, lupus and malaria ten years ago already knew their side effects on the heart. 

Although the FDA has granted hydroxychloroquine and chloroquine emergency authorization for the treatment of COVID-19 as early as a month ago, it was only earlier this week that hydroxychloroquine was approved by the FDA to enter the phase III clinical trial for the treatment of COVID-19.

In the report, the FDA mentioned that the FDA has not approved hydroxychloroquine and chloroquine for the treatment or prevention of COVID-19.

In the report, the FDA warned the public not to use hydroxychloroquine and chloroquine for treatment without authorization. 
The results of clinical trials have not yet been announced, and emergency authorizations for hydroxychloroquine and chloroquine only apply to inpatients. 
The FDA also encourages healthcare professionals to carefully screen and monitor each patient to help mitigate these risks.

Currently, clinical trials on hydroxychloroquine are underway

According to the Wall Street Journal, the researchers plan to recruit 200,000 patients to participate in more than 100 studies on hydroxychloroquine.

A few days ago, the clinical research data of the new crown "miracle drug" Remdesivir (Remdesivir) flowed out, and the results were not satisfactory. 
The anti-malarial drugs brought by Trump are in constant trouble.

During the COVID-19 pandemic, people from all walks of life in various countries hope to find effective medicines as soon as possible. But for medicines, experiments are still needed to prove their safety and effectiveness, and political public opinion cannot be a lever for controlling science.

hydroxychloroquine azithromycin causes heart disease in patients with new crown

In the situation where there is no cure for new crown pneumonia so far, US President Trump has always strongly recommended the antimalarial drug hydroxychloroquine as a magic drug for the treatment of the new crown, saying that "these drugs will be the game rules against the new crown virus."
However, more and more evidence is against Trump.
Simulation for Chloroquine and Hydroxychloroquine Treatment for COVID-19

However, more and more evidence is against Trump.

On April 24, local time, the top academic journal Nature Medicine published an online communication article from the New York University School of Medicine in the United States. 
The researchers investigated 84 new coronary pneumonia patients who were treated at a center in New York City. 

The patient was evaluated and claimed that patients with neocoronal pneumonia treated with hydroxychloroquine and azithromycin developed ECG abnormalities.

The article mentions that a recent report stated that the combined use of the antimalarial drug hydroxychloroquine and the antibiotic azithromycin (HY / AZ) may help patients with new coronary pneumonia, which has led clinicians around the world to adopt this program in large numbers.

Cardiac rhythm abnormalities due to Chloroquine

However, both of these drugs have previously been shown to increase the risk of different types of cardiac rhythm abnormalities, such as prolonged QT interval, drug-induced torsades de pointes (a polymorphic ventricular tachycardia), and drugs Sudden cardiac death. 

The QT interval is measured by an electrocardiogram and represents the total time course of ventricular depolarization and repolarization. 
The prolonged QT interval puts patients at risk of arrhythmia and sudden cardiac death.

In the medical center where the researchers are located, all patients with COVID-19 who had lower respiratory tract disease with cough, X-ray infiltration, persistent fever, with or without hypoxemia, were treated with hydroxychloroquine and azithromycin Chloroquine was taken 400 mg on the first day, twice daily, followed by 200 mg daily.

Azithromycin was 500 mg daily. The average ECG follow-up time after hydroxychloroquine and azithromycin treatment was 4.3 ± 1.7 days.

The researchers reviewed the electrocardiograms of 84 patients with new coronary pneumonia taking oral hydroxychloroquine and azithromycin and obtained their corrected QT (QTc) interval. The average age of patients in this group was 63 years, and 74% were male.

The results showed that on the 3.6 ± 1.6 days of treatment, the researchers observed an extension of QTc from a baseline mean of 435 ± 24 ms to a maximum mean of 463 ± 32 ms (Figure 1). 

11% (n = 9) of patients had a significantly longer QT interval, which put them at higher risk of arrhythmia and sudden cardiac death. Four patients died of multiple organ failure, with no evidence of arrhythmia or severe QT interval prolongation. 64 patients are still in hospital and the remaining 16 patients have been discharged.

The researchers quoted previous research in the paper as saying that as early as in February, Cell Research published online publications from the Institute of Virology, Chinese Academy of Sciences, WuhanInstitute of Virology, the Center for Biosafety Science, Xiao Zhifu, Hu Zhihong and the Academy of Military Medical Sciences.

Remdesivi and chloroquine can effectively inhibit new coronaviruses

Papers jointly published by Zhong Wu of the Institute of Pharmaceutical Sciences. They found in in vitro experiments that Remdesivi and chloroquine can effectively inhibit new coronaviruses. 

In addition, an early study in 2013 also showed that when hydroxychloroquine and azithromycin were applied to young healthy volunteers, QTc would be slightly prolonged. 

But in this study, the researchers found that QTc was significantly prolonged in COVID-19 patients receiving hydroxychloroquine and azithromycin.

The researchers believe that the differences in these findings suggest that the prolongation of the QT interval may be affected by factors such as the existence of the patient's underlying disease and the severity of the disease.

It is worth noting that a recent guideline from researchers at the Mayo Clinic in the United States, one of the world's leading medical institutions, recommends that patients with COVID-19 should undergo ECG screening before receiving new treatments including hydroxychloroquine and azithromycin Check and QTc assessment.
In this cohort study, 5 of 9 patients with significant QTc prolongation had normal QTc at baseline.

Therefore, the researchers concluded that the status of this type of patients should be continuously monitored, especially those with other diseases and those who receive other treatments that will lead to prolonged QT intervals.

Can one use hydroxychloroquine and chloroquine at will?

It is worth mentioning that just on April 24 local time, the US Food and Drug Administration (FDA) warned against using hydroxychloroquine and chloroquine at will. 

The FDA says that the two drugs hydroxychloroquine and chloroquine may have serious side effects, so they should only be used in hospital settings or clinical trials. 

The FDA said there were reports of "severe arrhythmias" in some patients with new coronary pneumonia when the drug was used in combination with azithromycin or other drugs that may affect the heart.

"We are also aware that more and more patients are prescribed these drugs through outpatient prescriptions," the FDA said. "Therefore, we want to alert healthcare professionals and patients to the known risks associated with hydroxychloroquine and chloroquine."

Prior to March 28, under Trump's strong recommendation and pressure, (FDA) had urgently authorized antimalarial drugs including hydroxychloroquine for the treatment of new coronary pneumonia. 
The decision was considered by relevant parties to damage the scientific authority of FDA.

On the same day on April 24th local time, the Journal of theAmerican Medical Association (JAMA) published a paper online from the Brazilian research team through a phase IIb randomized double-blind phase clinical trial recommendation for COVID-19. 

Higher dose of chloroquine phosphate should not be recommended

In critically ill patients, a higher dose of chloroquine phosphate should not be recommended because of its potential safety risks, especially when taken concurrently with azithromycin and oseltamivir. 
They believe that high-dose chloroquine treatment of COVID-19 critically ill patients is harmful and unhelpful, with more arrhythmias and failure to improve patient mortality. They have terminated the clinical trial.

Author's Bio

Name: Ian Skyler

Education: MBBS, MD

Occupation: Medical Doctor 

SpecializationCommunity Medicine, General Surgery, Natural Treatment

Experience: 18 Years as a Medical Practitioner

Share this in Public Information Interest>>


Popular posts from this blog

How to Soften and Clean Blood Vessels?

The savior that softens the blood vessels is found, eat daily, remove garbage and blood vessels clean slowly The blood vessels are densely packed in the human body, and there are many branches, which are complicated. Blood supplies oxygen and oxygen to various organs and tissues through these blood vessels to ensure the health of the body. Once there is a problem with blood vessels, it will affect blood transport and cause abnormal phenomena, which is very detrimental to health. Among them, the occurrence of blood clots in blood vessels is very serious. It can cause hardening and blockage of blood vessels, which is extremely detrimental to the health of blood vessels. For providing or getting the Best Telehealth, Telegym services and fitness networking may log in to   fitcj .com   network   What is Blood Clot? It is often referred to as blood clot. In general, there are many reasons for the formation of thrombosis, mainly due to age. Sedentary inactivity, high stress in life,

Organic Food in India Asia

  Organic food (Organic Foods) is also called ecological or biological food. Organic food is a relatively unified term for non-polluting natural food in the world. In India organic foods are getting popular at a very fast pace. Organic food usually comes from the organic agricultural production system and is produced and processed according to international organic agricultural production requirements and corresponding standards. In addition to organic food, some derivative products such as organic cosmetics, textiles, forest products or production materials provided by organic food, including biological pesticides and organic fertilizers, are collectively referred to as organic products after certification. Table of Contents 1. Definition ▪ Logo ▪ Differentiate 2. Main species ▪ Organic produce ▪ Judgment criteria 3. Apply for certification ▪ Certification requirements ▪ Organic certification mark ▪ Certification Difficulty

What is Biomechanics?

    The field of biophysics known as biomechanics (bio-mechanics) uses the principles and techniques of mechanics to the quantitative analysis of mechanical issues in living beings. Its studies cover everything from entire organisms to systems and organs (including blood, body fluids, organs, bones, etc.), from bird flying and fish swimming to flagella and cilia movement to the movement of body fluids in plants. The three laws of energy, momentum, and mass conservation as well as the constitutive equations characterising physical attributes form the foundation of biomechanics. Research in biomechanics focuses on mechanical issues that are connected to physiology and medicine. It can be separated into motion biomechanics, biofluid mechanics, and biosolid mechanics depending on the various research objects.     Bio-mechanics belongs to the branch of biophysics. The research scope ranges from biological whole to systems and organs.   Table of Contents 1. O